RWE & Modeling Summer Intern
Johnson & Johnson Innovative Medicine
Summary
The Evidence & Modeling Analytics Intern will support Innovative Scientific Analytics by strengthening the generation of high-quality evidence through economic modeling, literature review, and structured code validation. This role focuses on producing analytic inputs and outputs, including literature summaries, code searches and validation, and budget impact and cost-effectiveness models that translate data into meaningful insights for decision-making across the product lifecycle.
Job description
Purpose
The Evidence & Modeling Analytics Intern will support Innovative Scientific Analytics by strengthening the generation of high-quality evidence through economic modeling, literature review, and structured code validation. This role focuses on producing analytic inputs and outputs, including literature summaries, code searches and validation, and budget impact and cost-effectiveness models that translate data into meaningful insights for decision-making across the product lifecycle.
Responsibilities
- Assist in the development and validation of health economic models, including budget impact models, cost-per-responder analyses, and disease progression models.
- Support targeted literature reviews of published economic evaluations, clinical trials, and real-world studies to inform model structure, inputs, and assumptions.
- RWE and treatment guideline literature search, review, and summary. Code search and review: NDC, GPI, HCPCS, ICD-9 and ICD-10 diagnosis codes.
- Prepare presentation materials, integrating feedback from the supervisor and cross-functional project teams to ensure clarity and scientific excellence.
Qualifications / Requirements
- Currently enrolled in a PhD program in Health Economics, Biostatistics, Epidemiology, Decision Sciences, Operations Research, or a related quantitative field. Open to PharmD candidates or MS students with prior experience in consulting or industry, including developing de novo models.
- Foundational knowledge of pharmaceutical economic evaluation in the US market and comparative effectiveness methodologies, including network meta-analysis and matching-adjusted indirect comparison.
- Prior publication(s) involving cost-effectiveness analysis (e.g., manuscripts, conference presentations) is strongly preferred.
- Programming experience with Markov models, partitioned survival analysis, or discrete event simulation in Excel/VBA, R, or Python.
- Prior experience with health economic modeling in oncology, hematology, immunology, or neuroscience.
- Strong written and verbal communication skills, with the ability to explain complex health economic methods to both technical and non-technical audiences.
- Permanently authorized to work in the U.S., must not require sponsorship of an employment visa (e.g., H-1B or green card) at the time of application or in the future.
Requirements
- Currently enrolled in a PhD program in Health Economics, Biostatistics, Epidemiology, Decision Sciences, Operations Research, or a related quantitative field; PharmD candidates or MS students with consulting or industry experience may also qualify
- Foundational knowledge of pharmaceutical economic evaluation in the US market and comparative effectiveness methodologies, including network meta-analysis and matching-adjusted indirect comparison
- Programming experience with Markov models, partitioned survival analysis, or discrete event simulation in Excel/VBA, R, or Python
- Prior experience with health economic modeling in oncology, hematology, immunology, or neuroscience
- Strong written and verbal communication skills
- Permanently authorized to work in the U.S. without requiring sponsorship of an employment visa (e.g., H-1B or green card)
Benefits
- Medical Benefits
- Sick Time
- Pension Plan
Company overview
Johnson & Johnson Innovative Medicine is the pharmaceutical division of Johnson & Johnson, leading the way in medical innovation with a relentless focus on bringing transformational treatments to patients worldwide. The company applies rigorous science and compassion to address the most complex diseases of our time, developing groundbreaking medicines across key therapeutic areas including oncology, immunology, neuroscience, and cardiopulmonary medicine. With deep expertise and global reach, Johnson & Johnson Innovative Medicine reimagines how devastating diseases are treated and cured, delivering hope and better care for millions of patients and their families. The organization pioneers the path from laboratory research to clinical application, championing patients every step of the way while maintaining an unwavering commitment to scientific excellence and patient-centered innovation.